Vanguard Investments Australia »

Corcept Therapeutics Incorporated shares owned by Vanguard Investments Australia

Quarter-by-quarter ownership of Corcept Therapeutics Incorporated (CORT) shares owned by Vanguard Investments Australia from 13F filings

Historical chart of Vanguard Investments Australia investment in Corcept Therapeutics Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Corcept Therapeutics Incorporated held by Vanguard Investments Australia consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Corcept Therapeutics Incorporated by Vanguard Investments Australia

Quarter filed Position value Share count Share price at filing
2026-03-31 $978k 24k 40.31

More positions owned by Vanguard Investments Australia

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Vanguard Intl Equity Index F Ftse Europe Etf (VGK)
Eli Lilly & Co. (LLY)
JPMorgan Chase & Co. (JPM)
Exxon Mobil Corporation (XOM)
Berkshire Hathaway Inc Del Cl B New (BRK.B)

View all positions for Vanguard Investments Australia

Top funds holding Corcept Therapeutics Incorporated

BlackRock
Vanguard Group
Ingalls & Snyder
Renaissance Technologies
Vanguard Portfolio Management
Vanguard Capital Management
Parallel Advisors
State Street Corporation
Geode Capital Management
FMR
First Trust Advisors
Dimensional Fund Advisors
Tang Capital Management
Caption Management
UBS Group

View all funds holding Corcept Therapeutics Incorporated